Close menu




November 10th, 2025 | 07:35 CET

Instead of TKMS! Bitcoin takes off again! Strategy, Bitcoin Group, Coinbase, and Nakiki stock!

  • Bitcoin
  • crypto
  • Investments
Photo credits: pixabay.com

While defense stocks like TKMS are faltering, Bitcoin is holding above USD 100,000. After briefly dipping below this psychological barrier, short sellers were squeezed. The cryptocurrency is currently forming a bottom. This creates an ideal scenario for Nakiki. The Company, listed on the regulated market, is in the process of transforming itself into a Bitcoin Treasury company. Examples from abroad show that significant price gains are possible precisely in this early phase of the business model. Investors often prefer Treasury companies over direct investments, as Strategy recently demonstrated by raising millions. And what about Bitcoin Group?

time to read: 3 minutes | Author: Fabian Lorenz
ISIN: STRATEGY INC | US5949724083 , BITCOIN GROUP SE O.N. | DE000A1TNV91 , NAKIKI SE | DE000WNDL300

Table of contents:


    Nakiki shares: Is a 100% gain possible here too in just a few weeks?

    Bitcoin Treasury companies are regarded by investors as a kind of amplifier for Bitcoin's price performance. The most prominent example is Strategy (formerly MicroStrategy): under its colorful CEO Michael Saylor, the Company has transformed itself from a software provider to the largest private Bitcoin holder after Bitcoin inventor Nakamoto. Since then, Strategy shares have performed significantly better than Bitcoin itself. The business model is simple and consistent: Bitcoin is regularly bought – and not sold – through stock and bond placements. The concept has caught on internationally. Similar companies have emerged in Japan (Metaplanet), France (Capital B), the UK (The Smarter Web Company), and Brazil (Méliuz). What is striking is that the most significant price jumps often occurred around the time of the first Bitcoin purchases.

    This currently presents an exciting opportunity in Germany. Nakiki SE, which is listed on the regulated market, is currently transforming itself into a Bitcoin Treasury company. The first Bitcoins are to be purchased soon. The management team, led by CEO Andreas Wegerich – himself a major shareholder and experienced capital market player – has brought additional Bitcoin expertise on board with Marc Guilliard and other experts. To accompany the Bitcoin purchase, Nakiki is planning targeted corporate investments in the Bitcoin ecosystem. Negotiations are already underway with Companexis and the financial portal TopStonks. The ongoing income from such investments is intended to support operating costs and interest payments.

    Nakiki is already thinking strategically. The leap to the US Nasdaq stock exchange could take place as early as the first quarter of next year, which should provide the share price with further momentum. Also important for shareholders: it was recently announced that the 2024 half-year financial statements will need to be corrected. The loss will be significantly lower. The Company has parted ways with its tax advisor.

    At the virtual IIF investor conference, Nakiki's management presented its strategy and opportunities:

    https://youtu.be/3dbJ-VYfW40?si=VasxW8IGKmQ8TsRb

    Strategy: Raises EUR 620 million in Europe

    Michael Saylor has once again demonstrated that many investors prefer to invest in Treasury companies rather than directly in Bitcoin. The new euro-denominated "10% Series A Perpetual Stream Preferred Stock" was increased after strong demand, bringing Strategy EUR 620 million in cash. 7.75 million shares were placed at EUR 80 each. The original target was to raise only EUR 300 million. With the preferred shares, Strategy is specifically opening up to the European market. Michael Saylor commented: "Stream is the first digital credit instrument we have developed specifically for Europe."

    Strategically, the transaction is more than just fresh capital. It gives Strategy visibility among European addresses, diversifies its sources of financing across currency areas, and increases its flexibility to take advantage of market windows in a timely manner. In a volatile environment, these are precisely the building blocks that support the investment case - in the short term through clear financing prospects, and in the medium term through a larger, more stable investor base. The fact that the issue was significantly increased after an initially smaller approach underscores the strength of the placement and investors' confidence in the business model.

    Bitcoin Group wants to attack Coinbase and Bitpanda

    Nakiki and Strategy appear to be attracting more investor interest with their business models than Bitcoin Group. The latter was the pioneer in crypto trading in Germany with bitcoin.de. But after the Bitcoin hype in 2017, it missed the boat. This year alone, the stock has lost 38% of its value and is trading just below EUR 33. In 2017, it was EUR 78. So, over the last eight years, it has clearly underperformed Bitcoin.

    The Company now wants to turn the tide and develop the peer-to-peer marketplace into a modern trading platform. However, competition from companies such as Coinbase and Bitpanda appears to be overwhelming.

    The management of Bitcoin Group remains confident. CEO Moritz Eckert comments: "Everyone involved is working flat out on this project. We cannot wait to launch our new products, which are expected to be available in the first half of 2026. We see a great opportunity to use new technology and an outstanding user experience to sustainably inspire our existing customers for bitcoin.de and also to capture new market share from the competition. In addition to the existing private customer business on bitcoin.de, we will in future be launching a dedicated offering for small and medium-sized enterprises as well as institutional customers such as banks and family offices under the 'futurum' brand."


    Bitcoin appears to have found a floor. This level offers Nakiki an attractive entry point for Bitcoin purchases and investors the potential for notable price gains. In contrast, Bitcoin Group continues to face intense competition in crypto trading. Meanwhile, Strategy stays true to its core approach, accumulating Bitcoin on a massive scale.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Fabian Lorenz

    Fabian Lorenz

    For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.

    About the author



    Related comments:

    Commented by Carsten Mainitz on October 14th, 2026 | 05:30 CEST

    Tungsten, Weapons and Growth: Almonty, Rheinmetall and Deutz Under Review. Is This an Opportunity in a Megatrend?

    • Tungsten
    • Raw materials
    • Critical raw materials
    • Geopolitics
    • Defence industry
    • Armaments
    • Military
    • Supply chains
    • Investments

    The stock market is not linear. Greed and fear, excessive optimism or excessive scepticism—all of these drive markets. Only the future will tell what is cheap or expensive today. The stocks mentioned above are at precisely this point. Secure supply chains, access to raw materials and defence readiness are high on the agenda of Western governments. These long-term trends play strongly into the hands of defence companies and raw material producers. Almonty, in particular, as a producer of the critical raw material tungsten, holds a leading position in the sector. Where do the greatest opportunities lie for investors now?

    Read

    Commented by Carsten Mainitz on October 14th, 2026 | 05:25 CEST

    Who Profits When Patents Expire? The Billion-Euro Race Between Formycon, Fresenius and Pfizer

    • Biosimilar
    • FDA
    • Milestone
    • Cancer therapy
    • Pharma
    • Patents
    • Investments

    When patent protection for high-revenue biopharmaceuticals expires, a billion-euro market for follow-on products emerges. Michael Sen, head of the German healthcare group Fresenius SE, cites an impressive figure. By 2035, this could generate around EUR 180 billion in revenue. In particular, biosimilars, biotechnologically produced follow-on medicines that are highly similar in composition to the original medicine and equivalent in quality, efficacy and safety, are forecast to grow significantly. Moreover, biosimilars can strengthen competition and reduce treatment costs. Formycon stands out as a pure play. The company recently reached a crucial milestone. The US Food and Drug Administration (FDA) accepted the marketing authorisation application, the first publicly known application of its kind, for FYB206, a biosimilar candidate to the cancer medicine Keytruda, for review. Keytruda generates around USD 32 billion in annual revenue, making it the world's highest-revenue medicine. Fresenius is strengthening its positioning in the biosimilar sector through an acquisition. Pfizer needs new growth drivers. Who is best positioned for the year-end rally?

    Read

    Commented by Matthias Schomber on October 12th, 2026 | 05:24 CEST

    Every Crisis Creates an Opportunity: Nordex Stumbles, Jungheinrich Struggles, and RE Royalties Looks to Have Found a Bottom

    • Investments
    • Trading Opportunity
    • Technical Analysis
    • Rebound

    When market participants suddenly lose their nerve, and industrial heavyweights like Jungheinrich plunge to new multi-year lows despite bulging order books, a key question for private investors, among others, is whether this is a dangerous crisis with further downside ahead or an attractive entry opportunity. Nordex, too, has recently struggled to build on its successes from earlier this year. The share is trapped in a consolidation phase and has now returned to its level from late February, when it broke out upwards on high volume and with a long green weekly candlestick. Is this an attractive entry point for investors desperately seeking stable, high-yield alternatives in the future-oriented renewable energy market? Find out why scepticism could prevail regarding well-known German names and why a pioneer in royalty financing could be on the verge of the next major share price surge following a technical “textbook pattern”.

    Read